Status:
ENROLLING_BY_INVITATION
Evaluation of Retinal Parameters in Patients With Epiretinal Membrane After Vitrectomy
Lead Sponsor:
Pomeranian Medical University Szczecin
Conditions:
Epiretinal Membrane
Macular Oedema
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The goal of this interventional study is to assess the dynamics of structural and functional retinal changes in eyes with epiretinal membrane (ERM) after pars plana vitrectomy (PPV). Other study objec...
Eligibility Criteria
Inclusion
- Epiretinal membrane (ERM) - either associated with metamorphopsia or causing a marked reduction in best corrected visual acuity
- Pseudophakia
Exclusion
- Coexisting ocular or retinal diseases other than ERM
- Evidence of ocular inflammation or any active intraocular inflammatory process
Key Trial Info
Start Date :
May 9 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07165626
Start Date
May 9 2024
End Date
April 1 2027
Last Update
September 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First Department of Ophthalmology, Pomeranian Medical University
Szczecin, Poland